In August 2017, a total solar eclipse lasting not even three minutes was visible across 14 states in the United States. The event was marked by extensive media coverage since it was the first total eclipse in this country since 1918. News coverage showed crowds of people staring up into the sky and there was a sense of community as other global events temporarily became less important. The partial eclipse associated with this year's phenomenon ranged from Northern Canada to South America and even affected Western Europe, some of Africa and northeast Asia. 1 It seems this eclipse might have a corollary to perfusion practice: as advances in circulatory technologies steadily occur, will these developments eclipse the profession, totally or partially? Specifically and historically, when prolonged extracorporeal membrane oxygenation (ECMO) was used in the 1980s, patients treated were invariably neonates suffering from pulmonary failure. As experience accrued at established centers, pediatric patients and adults needing cardiac support, including some post-cardiotomy, were often treated. Today, neonates are no longer the dominant ECMO patient group and support of adults now predominates at most centers. 2 Indeed, the use of ECMO in adults increased 433% from 2006 to 2011. 3 Providing clinical coverage for this rising patient population has been unevenly distributed, depending on hospital manpower availability. In some centers, perfusionists are heavily involved in bedside management as well as choosing equipment, circuit assembly, priming and initiation. In others, the necessity of conducting cardiopulmonary bypass (CPB) procedures for cardiac surgery takes precedence and perfusionists are only involved peripherally or not at all. In the late 1980s to mid-1990s, the growing number of coronary artery bypass procedures mitigated against more perfusionist involvement with ECMO. It can be argued that the technology eclipsed the profession at this time.
Fast forward to the present and a partial eclipse has evolved. Indeed, now perfusionists in many centers are in the full sunlight of ECMO as perfusion teams not only advise or troubleshoot ECMO care, but they sit bedside shifts for the duration of extracorporeal support. Extracorporeal life support (ECLS), now the favored acronym that encompasses ECMO, is increasingly being taught in perfusion educational programs and is mandated by program-accreditation organizations. 4 Certification examinations test candidates on ECLS as well as ventricular assist technologies. Further confirmation of the importance of these non-CPB technologies is the recently published 4 th edition of the definitive textbook 5 edited by Gravlee and others that has been retitled, "Cardiopulmonary Bypass and Mechanical Support", which contains two chapters devoted to ECMO and three on ventricular assist devices (VADs).
As a relatively newer technology, VAD courses are also part of the perfusion student's curriculum, but hands-on with these devices may be much different, depending on the school or institutional practice. Students are taught the basics about the types of pumps, whether used for short-term or long-term applications. In some settings, they may even be "certified" by the VAD manufacturers. Long-term or socalled "durable" VADs, in most instances, are implanted electively in severely ill patients in the Operating Room, with or without CPB. However, dedicated mechanical circulatory support personnel (VAD or transplant coordinators) are often responsible for the assembly and operation of these circulatory support devices in this setting. Short-term VADs are more often used emergently in the Cardiac Catheterization Laboratory and, once again, perfusionist involvement may have changed significantly. Nursing personnel who have been trained to implement VAD support are often the ones who operate and transport these patients to the Intensive Care Unit.
So, what is the perfusion profession's stance on these developments? A position statement was issued in 2011 by the American Society of ExtraCorporeal Technology (AmSECT). 6 It was more of a strongly worded argument that perfusionists, as the group most qualified by training and experience in the management of extracorporeal devices, be involved either directly or in a supervisory role with all forms of circulatory support. More recently, the AmSECT membership has just approved a standards and guidelines document for mechanical circulatory support. 7 Like most such documents, it evolved and was revised over several years, with input from interested parties.
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Editorial Perfusion 32 (7) The language used in such a standard document is instructive: the word shall indicates a mandatory requirement and the word should indicates a recommendation. There are nine tenets or standards, with several specific practice guidelines, two appendices and a reference list covering many aspects of mechanical circulatory support. The underlying rationale for promulgation of standards is to promote safe patient care and, in this regard, they represent ideals. However, they should be grounded in reality. The shall statements (Standards 1-4) mandate that perfusionists participate in developing protocols because of their qualifications and competency with extracorporeal technologies. No argument there. Similarly, "Perfusionists shall be active participants in a multidisciplinary mechanical circulatory support program…" and documentation of procedures, including the use of checklists is called for in subsequent standards in the document. Again, there is no argument to dispute these mandates. However, the next Standard, number 5, on responsibilities, contains four guidelines using the word should, which means they are only recommendations that essentially call for perfusionist involvement by advocating protocols, instruction, troubleshooting and transport of VAD patients. In Standards 6-9, the operative word is, once again, shall, indicating mandatory requirements for safety, anticoagulation, quality assurance and improvement and equipment maintenance. These standards are derived from those found in earlier CPB standards, 8 but the current mandates may not reflect reality. It seems the management of patients receiving VADs will parallel what occurred with intra-aortic balloon pump technology: perfusionists may be present and assist in the implementation of the devices in the Operating Room, but, once the patient is transported to the Intensive Care Unit, perfusionist involvement is nil and especially so if the patient is discharged from the hospital. The largest group of VAD patients now is in the so-called destination therapy patient population and not bridge-totransplantation as was the case a decade ago. 9 The question arises: why this trend? It may be as it was three decades ago that there are insufficient numbers of perfusionists to assume responsibility for VADs. In preparing this editorial, several perfusion educators, program directors and thought leaders were contacted and the consensus opinion was that there is a pending or existent perfusionist shortage. Currently, the number of advertised job openings greatly exceeds the annual number of perfusion graduates. Scope and practices for perfusionists have expanded beyond traditional CPB. In the last eight issues of Perfusion, there have been 25 papers published on ECMO, including eight that were instructive case reports. During the same timeframe, there were only four VAD papers, so, by this benchmark, ECMO appears to have eclipsed VAD-related papers. Is this a momentary eclipse or will more reports on VAD technologies in the journal reappear in coming years? The current journal issue continues this trend with four ECMO studies (see Barbaro, Bilal, Mohite and Best), thus, confirming the relevance of this technology to our readers, as elucidated above.
